NCT00449202View on ClinicalTrials.gov

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2006

Conditions
Obesity
Interventions
DRUG

oleoyl-estrone (MP 101)

Trial Locations (3)

70808

Pennington Biomedical Research, Baton Rouge

84124

Jean Brown Research, Salt Lake City

Unknown

Swiss Pharma Contract, Basel

Sponsors
All Listed Sponsors
lead

Manhattan Pharmaceuticals

INDUSTRY